Molecular assay to predict recurrence of duke's b colon cancer

Details Molecular assay to predict recurrence of duke's b colon cancer Molecular assay to predict recurrence of duke's b colon cancer

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01)

Patent

CA 2644586

Assessing colorectal cancer status by determining differential expression of a collection of genes. Specially used to distinguish between relapsing and non-relapsing Duke's B operated patients.

L'invention porte sur l'évaluation de l'état d'un cancer colorectal par détermination de l'expression différentielle d'une collection de gènes. Cette évaluation est utilisée en particulier pour différencier les patients opérés au stade Dukes B faisant une rechute de ceux ne faisant pas de rechute.

Affiliated with

Also associated with

Rating

Molecular assay to predict recurrence of duke's b colon cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Molecular assay to predict recurrence of duke's b colon cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecular assay to predict recurrence of duke's b colon cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1342590